Immuron Limited American Depositary Shares
Symbol: IMRN (NASDAQ)
1.80
▼ (-1.37%) -0.025
Company Description:
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Key Stats
- Today's Open: $1.78
- Today's High: $1.834
- Today's Low: $1.75
- Today's Volume: 50.33K
- Yesterday Close: $1.82
- Yesterday High: $1.8377
- Yesterday Low: $1.66
- Yesterday Volume: 75.63K
- Last Min Volume: 0
- Last Min High: $1.796
- Last Min Low: $1.795
- Last Min VWAP: $0
Company Profile
- Name: Immuron Limited American Depositary Shares
- Website: https://www.immuron.com.au
- Listed Date: 2007-12-13
- Location: ,
- Market Status: Active
- CIK Number: 0001660046
- SIC Code:
- SIC description:
- Market Cap: $10.37M
- Round Lot: 100
- Outstanding Shares: 5.73M
- Asset Type: ADRC
RECENT FILINGS FOR IMRN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-15 | 6-K | View |
| 2025-08-13 | 6-K | View |
| 2025-07-21 | 6-K | View |
| 2025-07-18 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-06-04 | 6-K | View |
| 2025-05-30 | 6-K | View |
| 2025-04-11 | 6-K | View |
| 2025-04-10 | 6-K | View |
| 2025-03-07 | 6-K | View |
| 2025-03-05 | 6-K | View |
| 2025-02-28 | 6-K | View |
| 2025-02-19 | 6-K | View |
| 2025-01-17 | 6-K | View |
| 2025-01-15 | 6-K | View |
| 2025-01-14 | 6-K | View |
| 2025-01-10 | 6-K | View |
| 2025-01-08 | 6-K | View |
| 2024-12-10 | 6-K | View |
Latest News on IMRN